Articles
Today, there have been updates from two companies with therapies in phase 2 clinical trials for AGA. Initially, I posted the Follicum news to the Updates page, then I later found that Aclaris had released news as well. This was compelling enough to create an article for these news items. Follicum Trial Over 50% Enrolled…
Read More
The Brotzu lotion news keeps rolling in and things are getting interesting. First off, it was revealed this morning that the result photos from the Sitri Congress Pdf presentation were mislabeled between the 3 month and 6 month male result. I have now shown the accurate side-by-side comparison of the baseline to 6 month result…
Read More
Update: The full Brotzu presentation has been uploaded to Youtube by the Sitri organization. Coincidentally, and importantly, I’ve been told during this presentation (which is in Italian) Dr. Brotzu mentions that the male results photos were erroneously mislabeled in the pdf slide for the 3 month result and the 6 month result. This is, then, what…
Read More
The Brotzu lotion may be getting an important update this week. It has been confirmed that Dr. Brotzu will be presenting at the Spring Congress of the Italian Society for Hair Science and Restoration on April 14, 2018 in Naples, Italy. The topic of Dr. Brotzu’s presentation will be, of course, his esoteric hair growth…
Read More
As one of the top two hair growth treatments projected to reach the market in 2018, Replicel’s RCH-01 has a lot of people’s attention these days. When it was announced that the global cosmetic company Shiseido would trial Replicel’s hair growth technology in Japan, there was also talk from Shiseido that the treatment could reach…
Read More
Almost two months ago, a reader of Follicle Thought sent me an interesting article about new research being done in hair growth. The article I received was from a Turkish news website regarding an innovative gene therapy. I’ve done a bit of research on the topic since then and now will share my findings. Novartis Studying…
Read More
According to its latest press release, Aclaris Therapeutics will be launching a phase 2 trial for the use of JAK inhibitors in androgenic alopecia (pattern hair loss) within the next few months. Here’s the line item from the press release about Aclaris’ trial in androgenic alopecia. AGA-201 Topical – a planned Phase 2 open-label clinical trial…
Read More
Healthcare Venture Award Presentation: Update (10/31/23) Fukuda’s company TrichoSeeds was selected as a finalist at the 5th Healthcare Venture Award event which took place in Tokyo, Japan on October 27, 2023. The event featured innovative biotechnology companies from Japan, especially those which focused on extending healthspan and longevity. Follicle Thought was fortunate to capture an…
Read More
Hi Everyone, this is a check-in to keep you abreast of what’s going on with the website and to announce a few hair-growth news items. Yokohama and Fries, Please First, I’m pleased to announce I have an exclusive update regarding the “french fry hair growth” craze which was clobbering headlines around the world for the…
Read More
One of the most interesting companies working on a cellular hair growth therapy, HairClone of the UK, has just released their first newsletter update of 2018. The contents of the newsletter have been divided into business updates and scientific updates for the company. One of the updates mentions a crowdfunding campaign video from HairClone and…
Read More